Use of 8,9-dehydroestrone as an estrogen with neutral effects on prolactin levels

摘要

This invention provides a method of providing estrogen therapy or supplementation in a mammal in need thereof, wherein an elevation in prolactin levels concomitant with said estrogenic supplementation is undesirable in said mammal, which comprises administering an effective amount of 8,9-dehydroestrone or a pharmaceutically acceptable salt of its 3-sulfate ester to said mammal.